AP
IART icon

AHL Partners’s Integra LifeSciences IART Stock Holding History

AHL Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,661
Closed -$418K – 1257
2017
Q2 		$418K Sell
7,661
-5,683
-43% -$271K 0.01% 965
2017
Q1 		$562K Hold
13,344
– – 0.01% 935
2016
Q4 		$572K Sell
13,344
-2,968
-18% -$121K 0.02% 800
2016
Q3 		$673K Buy
16,312
+2,120
+15% +$88.8K 0.03% 713
2016
Q2 		$567K Buy
14,192
+5,194
+58% +$187K 0.03% 581
2016
Q1 		$303K Sell
8,998
-224
-2% -$6.98K 0.02% 670
2015
Q4 		$313K Sell
9,222
-11,902
-56% -$372K 0.02% 602
2015
Q3 		$629K Sell
21,124
-2,374
-10% -$74.2K 0.1% 291
2015
Q2 		$647K Buy
+23,498
New +$626K 0.03% 633

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AHL Partners's IART Position: Q3 2017 in Review

AHL Partners sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 7,661 shares — an estimated $418K sold.

AHL Partners first reported a position in IART in Q2 2015 and held it in 9 quarters. The position peaked at $673K in Q3 2016. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

  • AHL Partners reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
  • AHL Partners sold 7,661 Integra LifeSciences shares in Q3 2017, an estimated $418K.
  • AHL Partners first reported a position in Integra LifeSciences in Q2 2015 and held it in 9 quarters.
  • AHL Partners's Integra LifeSciences position peaked at $673K in Q3 2016.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on AHL Partners's 13F filing for Q3 2017, filed 14 Nov 2017.